Trending News
News
News
Pluristem Says Stem Cell Treatment Saves Patient
Company said that it has saved the life of a second patient with aplastic bone marrow, a condition in which the patient's bone marrow doesn't produce new blood cells.
News
Evaluation of Distinct Freezing Methods and Cryoprotectants for Human Amniotic Fluid Stem Cells Cryopreservation
Researchers from the University of São Paulo Medical School have evaluated the effects of two cryopreservation methods and four distinct cryoprotectants in the AFSCs viability and main characteristics maintenance after liquid nitrogen storage.
News
Stemgent Completes Acquisition of Asterand’s Human Tissue Business
The purchase of Asterand for $9 million is seen as a step in building leading research tools business focused on human cells.
News
Basic Science Students Introduced to their Role in Clinical and Translational Research
NIH piloting training program to encourage careers and partnerships.
News
IT Solutions for Privacy Protection in Biobanking
In this article, researchers from the University of Klagenfurt discuss current European public opinion on privacy issues and concerning informed consent, proposing IT solutions that help to harmonize research needs and societal demands.
News
New Research Could Increase Blood Supplies for Transfusions
A team of scientists has developed methods to increase the production of red blood cells from stem cells, a discovery that could dramatically boost the blood supply available for transfusions.
News
Researchers Build a Toolbox for Synthetic Biology
Engineers design new proteins that can help control novel genetic circuits in cells.
News
Transgenomic Reports Second Quarter 2012 Financial Results
Net sales for the second quarter of 2012 were $9.1 million compared with $7.7 million for the same period in 2011.
News
BGI partners with the University of Birmingham
Collaboration announced as a major joint initiative in environmental and human health research.
News
Silencing Investor Concerns? Alnylam Achieves RNAi Milestone
Alnylam Pharmaceutical received milestone payment from GSK as part of their ongoing collaboration to utilize Alnylam’s RNA interference (RNAi) technology to develop GSK’s cell-culture based influenza vaccine.
Advertisement